Kamby C
Rigshospitalet, København, onkologisk afdeling.
Ugeskr Laeger. 1991 Jul 22;153(30):2119-22.
The clinical course of recurrent breast cancer was compared in 117 patients with recurrence diagnosed at routine follow-up visits and 100 patients with recurrence detected in the interval between two scheduled follow-up visits. The interval recurrences were diagnosed after self-appointments (37 cases), after referral by general practitioners (31 cases) or other departments (32 cases). The two groups of patients were comparable with respect to age, menopausal status, initial stage of disease, and the type of adjuvant systemic therapy. The interval group of patients had a longer recurrence-free interval and also more symptoms than the routine group. The anatomical distribution of metastases was comparable in the two groups. The interval group of patients had a shorter survival after recurrence compared to the routine group (median 16 versus 25 months, p = 0.07). The survival from initial diagnosis was comparable in the two groups (48 versus 58 months, p = 0.67). Using multivariate Cox regression analysis, the influence of interval as compared with routine recurrences was evaluated in relationship to other prognostic variables (initial stage, recurrence-free interval, presence of visceral metastases, number of metastatic sites). In this model, the stage of disease, the recurrence-free interval, and presence of visceral metastases were the only significant independent prognostic factors.
对117例在常规随访中诊断为复发的乳腺癌患者和100例在两次预定随访间隔期间发现复发的患者的复发临床过程进行了比较。间隔期复发患者是在自行就诊后确诊的(37例)、经全科医生转诊后确诊的(31例)或经其他科室转诊后确诊的(32例)。两组患者在年龄、绝经状态、疾病初始阶段和辅助全身治疗类型方面具有可比性。间隔期复发组患者的无复发生存期更长,症状也比常规组更多。两组转移灶的解剖分布具有可比性。与常规组相比,间隔期复发组患者复发后的生存期更短(中位数分别为16个月和25个月,p = 0.07)。两组从初始诊断开始的生存期具有可比性(分别为48个月和58个月,p = 0.67)。使用多变量Cox回归分析,评估了与常规复发相比间隔期复发与其他预后变量(初始阶段、无复发生存期、内脏转移的存在、转移部位数量)之间的关系。在该模型中,疾病阶段、无复发生存期和内脏转移的存在是仅有的显著独立预后因素。